Nanovation Microtech P/E
Cos'è P/E di Nanovation Microtech?
P/E di Nanovation Microtech Inc. è N/A
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Technology settore su OTC rispetto a Nanovation Microtech
Cosa fa Nanovation Microtech?
Nanovation Microtech, Inc. develops and sells applications and games for iPhone, iPad, and Apple watches. The company was formerly known as Kalmin Corp. and changed its name to Nanovation Microtech, Inc. in July 2020. The company was founded in 2016 and is based in Copenhagen, Denmark. Nanovation Microtech, Inc. is a subsidiary of Greenfield International Limited.
Aziende con p/e simili a Nanovation Microtech
- Reliance Communications ha P/E di N/A
- Deveron UAS ha P/E di N/A
- Allbanc Split II ha P/E di N/A
- Biolife Sciences Inc ha P/E di N/A
- 4D pharma plc ha P/E di N/A
- CannaGrow ha P/E di N/A
- Nanovation Microtech ha P/E di N/A
- Pressure BioSciences ha P/E di N/A
- Pressure BioSciences ha P/E di N/A
- Pressure BioSciences ha P/E di N/A
- Norwegian Cruise Line ha P/E di N/A
- Pharmasimple SA ha P/E di N/A
- Pressure BioSciences ha P/E di N/A